Market Cap

Daito Pharmaceutical Co.,Ltd. Market Capitalization:

€358.2 Million

EUR as of Aug. 1, 2021

US$425.2 Million

business Daito Pharmaceutical Co.,Ltd. Company Profile

Daito Pharmaceutical Co.,Ltd. Main Stock Listing

FSX: DPA

Market Capitalization History of Daito Pharmaceutical Co.,Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $70.87 B
MERCK Kommanditgesellschaft auf Aktien $55.96 B
Takeda Pharmaceutical Company Limited $48.34 B
Haleon plc $46.46 B
Hansoh Pharmaceutical Group Company Ltd $23.59 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Daito Pharmaceutical Co.,Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2021 €400.1 M 0.00%
Jan. 1, 2020 €400.1 M 31.37%
Jan. 1, 2019 €304.6 M -19.07%
Jan. 1, 2018 €376.4 M 49.60%
Jan. 1, 2017 €251.6 M -17.31%
Jan. 1, 2016 €304.2 M 31.48%
Jan. 1, 2015 €231.4 M 69.01%
Jan. 1, 2014 €136.9 M -7.34%
Jan. 1, 2013 €147.8 M 2.87%
Jan. 1, 2012 €143.6 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Daito Pharmaceutical Co.,Ltd. Categories

Japan languages Healthcare languages Drug Manufacturers—Specialty & Generic
Japan Healthcare Japan Drug Manufacturers—Specialty & Generic

Stocks & Indices

Daito Pharmaceutical Co.,Ltd. has the following listings and related stock indices.


Stock: FSX: DPA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.